Current work indicates Anxa11 is closely associated with the LNM and 5-FU resistance of Hca-P cells, which suggests its potential application as an indicator for the lymphatic malignancy and chemoresistance of HCC. The gene discussed is ANXA11; the disease is hepatocellular carcinoma.